Overall Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Last Updated: Republic Top 10 Headlines: US-Canada Heatwave; Covaxin Efficacy Update; TN Lockdown & More Punjab govt to take action against Sidhu; Netizens share tales as heatwave grips US-Canada; Covaxin clocks 77.8% overall efficacy against COVID BJP Explains Uttarakhand CM Tirath Singh Rawat's Resignation; Says 'can't Hold Bypolls' As BJP shuffles the Uttarakhand CM again, BJP MLA Rajesh Shukla explained Tirath Singh Rawat's resignation, citing the inability to hold by-elections amid COVID-19. Rawat, who had resigned as BJP's Garhwal MP, has to be elected to the Uttarakhand Assembly w...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Reportable 15 Jun 2021, 01:16 GMT+10 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial GAITHERSBURG, Md., June 14, 2021 - Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoi...

Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting News provided by Share this article Share this article INDIANAPOLIS, May 19, 2021 /PRNewswire/ -- New data from across Eli Lilly and Company's (NYSE: LLY) oncology portfolio will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 4-8, 2021. The data include new analyses of Verzenio ® (abemaciclib) from the Phase 3 monarchE trial in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) ear...

The Chinese Sinovac vaccine has been found to be far less effective than vaccines developed by Pfizer-BioNTech and Moderna, according to a Brazil government sta